Dear reader,
This issue of Human Vaccines & Immunotherapeutics starts with ten articles on Licensed Vaccines, including research reports on the impact of the aging population on the burden of vaccine-preventable diseases in U.S. (Talbird, p 332), Australian GPs’ views on pertussis vaccination of adults (Bayliss, p 344), a Phase 3 trial of safety and immunogenicity of the purified Vero-cell cultured rabies vaccine (Shen, p 351), anti-varicella antibody levels in Chinese subjects of all age groups (Meng, p 358), concurrent increase of varicella prevalence and poor vaccine compliance in China (Liu, p 363), varicella serostatus in Italian healthcare workers (HCWs) and medical students (Balbi, p 372), decrease in anti-rubella antibody levels between antenatal and postpartum periods in pregnant women (Rasool, p 377), development of an ELISA for determining levels of coxsackievirus A16 vaccine antigen (Cui, p 381), seroprevalence of anti-polio antibodies in response to vaccine change in Beijing (Li, p 389), and a Letter to the Editor on Hib and pneumococcal conjugate vaccination in Malawi (Gadama, p 397).
The Coronavirus section features a review of routine vaccination strategies in the pandemic (Dinleyici, p 400), a survey of willingness to be vaccinated among the Chinese (Yang, p 408), commentaries on vaccine development and use (Rahman, p 414) and use of BCG vaccine for prevention of severe Covid-19 disease (Fedeli, p 416), and a Letter to the Editor on vaccine clinical trials in Nepal (Gupta, p 418).
Five research articles on HPV investigate declining vaccine awareness in U.S. (Chido-Amajuoyi, p 420), disparities of vaccine uptake based on sexual orientation in women (Adjei Boakye, p 428), the association of vaccine status with intention to undergo cervical screening in young women (Kakubari, p 434), impact of an educational intervention on HCWs’ knowledge and attitudes to vaccination (Chen, p 443), and a school-based intervention in Canada (Dubé, p 451).
Four Influenza studies report on determinants of parental vaccine acceptance (Zhao, p 457), keys to acceptance among high-risk groups in Peru (González-Block, p 465), immunogenicity of H5N1 vaccines in the elderly (Zhang, p 475), and immunogenicity of a gamma radiation-inactivated vaccine (Chen, p 485).
The Rotavirus section presents a survey of opinions and attitudes of Italian HCWs to non-compulsory vaccination (Amadori, p 497), a report on vaccine effectiveness and impact in Uzbekistan (Eraliev, p 503), and a study of self-financed vaccine effect on acute pediatric gastroenteritis in Turkey (Gönüllü, p 510).
The segment on Pneumococcal vaccines introduces a study on the effect of PCV on otitis media in children (Edmondson-Jones, p 517), a survey of barriers to vaccination completion among the elderly in Hong Kong (Wang, p 527), and a commentary on the impact of PCV on mortality of children under five (Camargos, p 537).
An Immunotherapy review discusses immune checkpoint inhibitors in glioblastoma (Yang, p 546).
Two short reports on Novel Vaccines include a safety and immunogenicity trial of Sendai virus-based vaccine for human parainfluenza (Scaggs Huang, p 554) and a study on the stabilization of a protective antigen in anthrax vaccine (Ryabchevskaya, p 560).
The Hepatitis B section presents a report on factors associated with reduced vaccine immunogenicity (Yin, p 566), and a Letter to the Editor on the vaccine booster dose in subjects with health conditions (Sticchi, p 575) with an associated Response Letter (Bechini, p 580).
Two articles on Acceptance include a survey of parental vaccine views following a drop in coverage in an Italian region (Brunelli, p 583) and a commentary on medical prctitioners’ attitudes towards the use of a vaccination decision aid (Frawley, p 588).
Finally in this issue we highlight a Public Health report on variation in vaccine coverage in rural China (He, p 592) and a review on the Technology of outer membrane vesicles as vaccines (Rossi, p 601).
Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam Weiss, PhD
Acquisitions Editor